TAMMY YOUNG, M.D.
Medical Oncology Physician · JACKSON, MS
Individual Active NPI 1013911668
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,506 | 464,459 | $40,880,813 | $13,743,078 | $10,961,718 |
| 2023 | 1,441 | 472,560 | $38,099,058 | $11,441,745 | $9,116,857 |
| 2022 | 1,353 | 515,134 | $36,887,848 | $11,307,422 | $9,016,477 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 56,600 | $55 | $44 |
| J0185 | Injection, aprepitant, 1 mg | 40,950 | $2 | $1 |
| J9299 | Injection, nivolumab, 1 mg | 39,900 | $31 | $24 |
| J0897 | Injection, denosumab, 1 mg | 32,040 | $25 | $20 |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 28,400 | $14 | $11 |
| J9267 | Injection, paclitaxel, 1 mg | 23,520 | $0 | $0 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 19,932 | $26 | $21 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 18,700 | $0 | $0 |
| J9075 | Injection, cyclophosphamide, not otherwise specified, 5 mg | 11,400 | $1 | $1 |
| J9022 | Injection, atezolizumab, 10 mg | 8,808 | $82 | $66 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,378 | $0 | $0 |
| J1930 | Injection, lanreotide, 1 mg | 8,160 | $42 | $34 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 14971 | MS |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Mississippi
- NPI 1306043278
- NPI 1710921895
- NPI 1619913928
- NPI 1487659850
- NPI 1518178524
- NPI 1639380207
- NPI 1356838783
- NPI 1154367837
See all Medical Oncology Physician providers in Mississippi →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.